Artelo Biosciences Announces ART27.13 Achieved Weight Loss Comparable to Semaglutide as a Monotherapy and Doubled Weight Loss in Combination with Semaglutide in a Nonclinical Model of Obesity

Artelo Biosciences (ARTL) reported that ART27.13, a dual cannabinoid receptor agonist, matched semaglutide's weight loss in an obesity model and showed enhanced effects when combined. ART27.13 reduced body weight by 20% alone and 40% with semaglutide, primarily through fat loss. The company plans to explore partnering opportunities for metabolic disease treatments.

Nvidia's supply commitments surged to $279B, driven by memory needs, impacting its gross margins (75% in Q2, expected to drop to 71%-72%). Micron, a key memory supplier, reported strong fiscal Q3 results ($41.46B revenue, $28.24B net income) and high margins (83%-87%). Micron's HBM4 memory is critical for Nvidia's AI chips, creating a supply bottleneck. Micron's CEO noted HBM's high wafer consumption limits conventional DRAM supply, affecting industries like smartphones.

Censys reported a critical IBM MQ vulnerability (CVE-2026-10747) enabling remote code execution or denial-of-service. IBM MQ web consoles were found on 120 hosts and 149 web properties. IBM released fixes, but no exploitation has been reported. Censys offers tools for exposure assessment, potentially aiding its brand and customer acquisition.

NVIDIA CEO Jensen Huang highlighted memory and silicon photonics as AI bottlenecks, with Micron, Coherent, and Tower Semiconductor positioned to benefit. Micron leads in high-bandwidth memory, Coherent supplies photonics components, and Tower Semiconductor manufactures wafers. NVIDIA expects 70% revenue growth, and analysts note supply constraints and pricing power in these sectors.

Apple's new MacBook Neo, priced at $599, shipped 1.1 million units in its first three weeks, driving a 23% year-over-year growth in Mac shipments. The overall laptop market is forecast to decline 11% in 2026, according to Counterpoint Research. The Neo's success is attributed to its use of the A18 Pro chip, lower component costs, and strong demand in key markets. Rivals face pricing pressure due to memory shortages, with some Windows laptops seeing significant price increases.

Daishin Securities maintained a 'Buy' rating and ₩560,000 ($410) target price for Samsung Electronics (005930.KS), citing a strong semiconductor upcycle and HBM leadership. The target implies 104% upside from the current price. Analysts highlighted long-term contracts, improved HBM competitiveness, and potential changes to shareholder return policies.